David Carney

Title: David Carney - Innovator in Mass Spectrometry Assays

Introduction

David Carney is a notable inventor based in Derry, NH (US). He has made significant contributions to the field of mass spectrometry, particularly in the development of assays that identify compounds activating deacetylases. His work has implications for understanding protein modulation and its effects on various biological processes.

Latest Patents

David Carney holds 1 patent for his invention titled "Mass spectrometry assays for identifying compounds that activate deacetylases." This patent provides methods for determining the activity of proteins that modulate the acetylation state of a protein substrate. The methods are designed to assess both acetyltransferase and deacetylase activity. By utilizing mass spectrometry, these methods can determine the acetylation state of substrate peptides and identify compounds that influence the activity of proteins with acetyltransferase or deacetylase functions.

Career Highlights

David Carney is currently associated with Sirtris Pharmaceuticals, Inc., where he applies his expertise in mass spectrometry and protein activity modulation. His innovative approaches have contributed to advancements in the understanding of protein interactions and their regulatory mechanisms.

Collaborations

Throughout his career, David has collaborated with notable colleagues, including Jesse Smith and Jill C Milne. These partnerships have fostered a collaborative environment that enhances research and development in the field of biochemistry.

Conclusion

David Carney's work in mass spectrometry and protein activity modulation exemplifies the impact of innovative thinking in scientific research. His contributions continue to advance our understanding of complex biological systems and their regulation.